Qualitative Change in Migraine Prevention? | Zendy

Cady Roger | Zendy; Lipton Richard B. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Qualitative Change in Migraine Prevention?

Author(s) -

Cady Roger,

Lipton Richard B.

Publication year - 2018

Publication title -

headache: the journal of head and face pain

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.14

H-Index - 119

eISSN - 1526-4610

pISSN - 0017-8748

DOI - 10.1111/head.13354

Subject(s) - migraine , calcitonin gene related peptide , medicine , calcitonin , qualitative analysis , qualitative research , neuropeptide , receptor , social science , sociology

A new generation of drugs that target calcitonin gene‐related peptide (CGRP) pathways offers a unique opportunity to explore the relationship between responder rates (RRs) and improvement in patient outcomes. The authors hypothesize a “tipping point” exists for patients with a ≥75% migraine response. They propose higher RRs reported in trials with CGRP inhibitory antibodies deliver not only a quantitative change in monthly headache days, but also a qualitative change in function, for a clinically meaningful subpopulation of patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research